The Mediterranean food pattern: a good recipe for patients with the metabolic syndrome

  • C. A. Vidurrizaga-De Amezaga
  • M. A. Zulet
  • A. Marti
  • M. A. Martinez-Gonzalez
  • J. A. Martinez


The metabolic syndrome is a complex condition characterized by dyslipidaemia, high blood pressure, impaired glucose tolerance and abdominal fat accumulation. Subjects with the metabolic syndrome are at high risk of atherosclerosis and coronary heart disease. A comprehensive approach is required for patients suffering this cluster of clinical manifestations. Indeed, subjects with the metabolic syndrome could benefit from life-style modifications, particularly through exercise and diet. In this article, the evidence regarding the role of diet, in particular the role of food patterns based on the Mediterranean-style diet, in preventing and treating the metabolic syndrome are reviewed.


Mediterranean diet Metabolic syndrome Diet 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kylin E (1923) Studien uber das Hypertonie-Hyperglykamie-Hyperurikamiesyndrom. Zentralbl Inn Med 44:105–127Google Scholar
  2. 2.
    Vague J (1947) La diffférenciacion sexuelle, facteur déterminant des formes de l’obésité. Presse Med 30:339–340Google Scholar
  3. 3.
    Avogaro P, Crepaldi G, Enzi G, Tiengo A (1967) Associazione di iperlipidemia, diabete mellito e obesità di medio grado. Acta Diabetol Lat 4:572–590Google Scholar
  4. 4.
    Phillips GB (1978) Sex hormones, risk factors and cardiovascular disease. Am J Med 65:7–11Google Scholar
  5. 5.
    Phillips GB (1977) Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction. Proc Natl Acad Sci U S A 74:1729–1733Google Scholar
  6. 6.
    Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595–1607Google Scholar
  7. 7.
    Alberti KG, Zimmet P (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553Google Scholar
  8. 8.
    Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute (2005) Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752Google Scholar
  9. 9.
    Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome — a new worldwide definition. Lancet 366:1059–1062Google Scholar
  10. 10.
    Hanley AJ, Karter AJ, Williams K, Festa A, D’Agostino RB Jr, Wagenknecht LE, Haffner SM (2005) Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 112:3713–3721Google Scholar
  11. 11.
    Moebus S, Hanisch JU, Aidelsburger P, Bramlage P, Wasem J, Jöckel KH (2007) Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 6:22Google Scholar
  12. 12.
    Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO (2007) Impact of cardiometabolic risk factor clusters on health-related quality of life in the US. Obesity 15:511–521Google Scholar
  13. 13.
    Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ (2005) Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112:666–673Google Scholar
  14. 14.
    Malik S, Wong ND, Franklin SS, Kamath TV, L’Italien GJ, Pio JR, Williams GR (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in the United States Adults. Circulation 110:1245–1250Google Scholar
  15. 15.
    Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716Google Scholar
  16. 16.
    Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952Google Scholar
  17. 17.
    Kurl S, Laukkanen JA, Niskanen L, Laaksonen D, Sivenius J, Nyyssonen K, Salonen JT (2006) Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37:806–811Google Scholar
  18. 18.
    Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108:414–419Google Scholar
  19. 19.
    McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G (2005) The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities study. Diabetes Care 28:385–390Google Scholar
  20. 20.
    Wilson PWF, D’Agostino RB, Parise H, Sillivan L, Meigs JB (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112:3066–3072Google Scholar
  21. 21.
    Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM (2002) Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25:2016–2021Google Scholar
  22. 22.
    Esposito K, Pontillo A, Giugliano F, Giugliano G, Marfella R, Nicoletti G, Giugliano D (2003) Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 88:1055–1058Google Scholar
  23. 23.
    Tamakoshi K, Yatsuya H, Kondo T, Hori Y, Ishikawa M, Zhang H, Murata C, Otsuka R, Zhu S, Toyoshima H (2003) The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 27:443–449Google Scholar
  24. 24.
    Ridker PM, Buring JE, Cook NR, Rifai N (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107:391–397Google Scholar
  25. 25.
    Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972–978Google Scholar
  26. 26.
    Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D’Andrea F, Molinari AM, Giugliano D (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105:804–809Google Scholar
  27. 27.
    Lakka TA, Laaksonen DE (2007) Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 32:76–88Google Scholar
  28. 28.
    US Department of Health and Human Services (1996) Physical activity and health: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GAGoogle Scholar
  29. 29.
    Pitsavos C, Panagiotakos DB, Weinem M, Stefanadis C (2006) Diet, exercise and the metabolic syndrome. Rev Diabet Stud 3:118–126Google Scholar
  30. 30.
    Feldeisen SE, Tucker KL (2007) Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl Physiol Nutr Metab 32:46–60Google Scholar
  31. 31.
    James PT, Rigby N, Leach R (2004) The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 11:3–8Google Scholar
  32. 32.
    Wirfält E, Hedblad B, Gullberg B, Mattisson I, Andrén C, Rosander U, Janzon L, Berglund G (2001) Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the Malmo Diet and Cancer cohort. Am J Epidemiol 154:1150–1159Google Scholar
  33. 33.
    Mennen LI, Lafay L, Feskens EJM, Novak M, Lepinay P, Balkau B (2000) Possible protective role of bread and dairy products on the risk of the metabolic syndrome. Nutr Res 20:335–347Google Scholar
  34. 34.
    McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF (2004) Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham offspring cohort. Diabetes Care 27:538–546Google Scholar
  35. 35.
    Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, St Jeor S, Suttie J, Tribble DL, Bazzarre TL (2000) AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102:2284–2299Google Scholar
  36. 36.
    Robertson RM, Smaha L (2001) Can a Mediterranean style diet reduce heart disease? Circulation 103:1821–1822Google Scholar
  37. 37.
    Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548–2556Google Scholar
  38. 38.
    Shipp J, Opie LH, Challoner DR (1961) Fatty acid and glucose metabolism in the perfused heart. Nature 189:1018–1019Google Scholar
  39. 39.
    Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, Defronzo RA, Cusi K (2005) Dose-response effect of elevated plasma free fatty acid on insulin signalling. Diabetes 54:1640–1648Google Scholar
  40. 40.
    Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME (2005) Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes. J Hypertens 23:463–473Google Scholar
  41. 41.
    Syvanne M, Taskinen MR (1997) Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus. Lancet 350[Suppl 1]:S120–S123Google Scholar
  42. 42.
    Laclaustra-Gimeno M, Bergua-Martinez C, Pascual-Calleja I, Casanovas-Lenguas JA (2006) Síndrome metabólico: concepto y fisiología. Rev Esp Cardiol 5:3–10Google Scholar
  43. 43.
    DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194Google Scholar
  44. 44.
    Fukuchi S, Hamaguchi K, Seike M, Himeno K, Sakata T, Yoshimatsu H (2004) Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats. Exp Biol Med 229:486–493Google Scholar
  45. 45.
    Moreno-Aliaga MJ, Campion J, Milagro FI, Berjon A, Martinez JA (2005) Adiposity and proinflammatory state: the chicken or the egg. Adipocytes 1:1–16Google Scholar
  46. 46.
    Martinez JA (2006) Mitochondrial oxidative stress and inflammation: an slalom to obesity and insulin resistance. J Physiol Biochem 62:303–306CrossRefGoogle Scholar
  47. 47.
    Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Wright AD, Turner RC, Holman RR (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412Google Scholar
  48. 48.
    García-Moll X, Kaski JC (1999) Cardiopatía isquémica: marcadores de inflamación y riesgo cardiovascular. Rev Esp Cardiol 52:990–1003Google Scholar
  49. 49.
    García-Moll X (2005) Marcadores de inflamación y de antiinflamación en el síndrome coronario agudo: listos para usarlos en la práctica clínica? Rev Esp Cardiol 58:615–617Google Scholar
  50. 50.
    Martínez de Morentin BE, Rodríguez MC, Martínez JA (2003) Síndrome metabólico, resistencia a la insulina y metabolismo tisular. Endocrinol Nutr 50:324–333Google Scholar
  51. 51.
    Reilly MP, Rader DJ (2003) The metabolic syndrome: more than sum of its parts? Circulation 108:1546–1551Google Scholar
  52. 52.
    US Department of Health and Human Services. Third National Health and Nutrition Examination Survey (NHANES III). Advance Data Nos. 255 and 258. National Center for Health Statistics, Centers for Disease Control and PreventionGoogle Scholar
  53. 53.
    Grundy SM (2004) Obesity, metabolic syndrome and cardiovascular disease. J Clin Endocrinol Metab 89:2595–2600Google Scholar
  54. 54.
    Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359Google Scholar
  55. 55.
    Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K, DECODE Study Group (2004) Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med 164:1066–1076Google Scholar
  56. 56.
    Ferrannini E, Natali A (1991) Essential hypertension, metabolic disorders, and insulin resistance. Am Heart J 121:1274–1282Google Scholar
  57. 57.
    Santos AC, Lopes C, Barros H (2004) Prevalence of metabolic syndrome in the city of Porto. Rev Port Cardiol 23:45–52Google Scholar
  58. 58.
    Oh JY, Hong YS, Sung YA, Barrett-Connor E (2004) Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 27:2027–2032Google Scholar
  59. 59.
    National Institutes of Health (1993) National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MDGoogle Scholar
  60. 60.
    Kannel WB, McGee DL, Gordon T (1976) A general cardiovascular risk profile: The Framingham Study. Am J Cardiol 38:46–51Google Scholar
  61. 61.
    Appel L, Moore T, Obarzanek E, Vollmer W, Svetkey L, Sacks F, Bray G, Vogt T; DASH Collaborative Research Group (1997) A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336:1117–1124Google Scholar
  62. 62.
    Wood D (2001) Established and emerging cardiovascular risk factors. Am Heart J 141:49–57Google Scholar
  63. 63.
    World Health Organization (2003) Diet, nutrition, and the prevention of chronic diseases. Technical Report Series 916. World Health Organization, GenevaGoogle Scholar
  64. 64.
    McKeown NM, Neigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF (2004) Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring cohort. Diabetes Care 27:613–614Google Scholar
  65. 65.
    Vrolix R, van Meijl LE, Mensink RP (2007) The metabolic syndrome in relation with the glycemic index and the glycemic load. Physiol Behav. DOI: 10.1016/j.physbeh.2007.11.052Google Scholar
  66. 66.
    Yudkin J (1967) Sugar and ischaemic heart disease. Practitioner 198:680–683Google Scholar
  67. 67.
    Yudkin J (1978) Dietary factors in atherosclerosis: sucrose. Lipids 13:370–372Google Scholar
  68. 68.
    Ernst N, Fisher M, Smith W, Gordon T, Rifkind BM, Little JA, Mishkel MA, Williams OD (1980) The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. The Lipid Research Clinics Prevalence Study. Circulation 62:IV41–IV52Google Scholar
  69. 69.
    US-USSR Steering Committee for Problem Area I (1984) Nutrient intake and its association with high-density lipoprotein and low-density lipoprotein cholesterol in selected US and USSR subpopulations. The US-USSR Steering Committee for Problem Area I: the pathogenesis of atherosclerosis. Am J Clin Nutr 39:942–952Google Scholar
  70. 70.
    Archer SL, Liu K, Dyer AR, Ruth KJ, Jacobs DR Jr, Van Horn L, Hilner JE, Savage PJ (1998) Relationship between changes in dietary sucrose and high density lipoprotein cholesterol: the CARDIA Study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 8:433–438Google Scholar
  71. 71.
    Preuss HG, Zein M, MacArthy P, Dipette D, Sabnis S, Knapka J (1998) Sugar-induced blood pressure elevations over the life-span of three substrains of Wistar rats. J Am Coll Nutr 17:36–47Google Scholar
  72. 72.
    Sherman WM (1995) Metabolism of sugars and physical performance. Am J Clin Nutr 62[Suppl 1]:228S–241SGoogle Scholar
  73. 73.
    de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM (2007) Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PloS Med 4:e261Google Scholar
  74. 74.
    Beulens JW, de Bruijne LM, Stolk RP, Peeters PH, Bots ML, Grobbee DE, van der Schouw YT (2007) High dietary glycemic load and glycemic index increase risk of cardiovascular disease among middle-aged women: a population-based follow-up study. J Am Coll Cardiol 50:14–21Google Scholar
  75. 75.
    Halton TL, Willett WC, Liu S, Manson JE, Albert CM, Rexrode K, Hu FB (2006) Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med 355:1991–2002Google Scholar
  76. 76.
    Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM, Ludwig DS (2007) Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. JAMA 297:2092–2102Google Scholar
  77. 77.
    Maki KC, Rains TM, Kaden VN, Raneri KR, Davidson MH (2007) Effects of a reduced-glycemic-load diet on body weight, body composition, and cardiovascular disease risk markers in overweight and obese adults. Am J Clin Nutr 85:724–734Google Scholar
  78. 78.
    Chiu CJ, Hubbard LD, Armstrong J, Rogers G, Jacques PF, Chylack LT Jr, Hankinson SE, Willett WC, Taylor A (2006) Dietary glycemic index and carbohydrate in relation to early age-related macular degeneration. Am J Clin Nutr 83:880–886Google Scholar
  79. 79.
    Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC (2007) A prospective study of dietary carbohydrate quantity and quality in relation to risk of ovulatory infertility. Eur J Clin Nutr. DOI: 10.1038/sj.ejcn.1602904Google Scholar
  80. 80.
    Strayer L, Jacobs DR Jr, Schairer C, Schatzkin A, Flood A (2007) Dietary carbohydrate, glycemic index, and glycemic load and the risk of colorectal cancer in the BCDDP cohort. Cancer Causes Control 18:853–863Google Scholar
  81. 81.
    Abete I, Parra D, Martinez JA (2008) Energy-restricted diets based on a distinct food selection affecting the glycemic index induce different weight loss and oxidative response. Clin Nutr. DOI: 10.1016/j.clnu.2008.01.005Google Scholar
  82. 82.
    Life Sciences Research Office (1987) Physiological effects and health consequences of dietary fiber. Federation of American Societies for Experimental Biology, Bethesda, MD, p 236Google Scholar
  83. 83.
    Marlett JA, Hosig KB, Vollendorf NW, Shinnick FL, Haack VS, Story JA (1994) Mechanism of serum cholesterol reduction by oat bran. Hepatology 20:1450–1457Google Scholar
  84. 84.
    Anderson JW, Story L, Sieling B, Chen WJ, Petro MS, Story J (1984) Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men. Am J Clin Nutr 40:1146–1155Google Scholar
  85. 85.
    Davidson MH, Dugan LD, Burns JH, Bova J, Story K, Drennan KB (1991) The hypocholesterolemic effects of beta-glucan in oat-meal and oat bran: a dose-controlled study. JAMA 265:1833–1839Google Scholar
  86. 86.
    Kritchevsky D (1986) Dietary fiber and atherosclerosis. In: Vahouny GV, Kritchevsky D (eds) Dietary fiber: basic and clinical aspects. Plenum Press, New York, pp 265–274Google Scholar
  87. 87.
    Morris JN, Marr JW, Clayton DG (1977) Diet and heart: a post-script. Br Med J 2:1307–1314Google Scholar
  88. 88.
    Pereira MA, O’Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, Knekt P, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Ascherio A (2004) Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 164:370–376Google Scholar
  89. 89.
    Dodson PM, Pacy PJ, Cox EV (1985) Long-term follow-up of the treatment of essential hypertension with a high-fiber, low-fat and low-sodium dietary regimen. Hum Nutr Clin Nutr 39C:213–220Google Scholar
  90. 90.
    Rouse IL, Armstrong BK, Beilin LJ (1983) The relationship of blood pressure to diet and lifestyle in two religious populations. J Hypertens 1:65–71Google Scholar
  91. 91.
    Rouse IL, Beilin LJ, Mahoney DP, Margetts BM, Armstrong BK, Record SJ, Vandongen R, Barden A (1986) Nutrient intake, blood pressure, serum and urinary prostaglandins and serum thromboxane B2 in a controlled trial with a lacto-ovo-vegetarian diet. J Hypertens 4:241–250Google Scholar
  92. 92.
    Anderson JW, Smith BM, Gustafson NJ (1994) Health benefits and practical aspects of high-fiber diets. Am J Clin Nutr 59[Suppl]:1242S–1247SGoogle Scholar
  93. 93.
    Rössner S, von Zweigbergk D, Ohlin A, Ryttig K (1987) Weight reduction with dietary fibre supplements: results of two double-blind randomized studies. Acta Med Scand 222:83–88Google Scholar
  94. 94.
    National Academy of Sciences (1989) Diet and health. National Academy Press, Washington, DCGoogle Scholar
  95. 95.
    Anderson JW (1985) High-fiber diets for obese diabetic men on insulin therapy: short-term and long-term effects. In: Vahouny GV (ed) Dietary fiber and obesity. Liss, New York, pp 133–159Google Scholar
  96. 96.
    Salmerón J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, Stampfer MJ, Wing AL, Willett WC (1997) Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20:545–550Google Scholar
  97. 97.
    Salmerón J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC (1997) Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277:472–477Google Scholar
  98. 98.
    Crujeiras A, Parra D, Abete I, Martinez JA (2007) A hypocaloric diet enriched in legumes specifically mitigates lipid peroxidation in obese subjects. Free Radic Res 41:496–506Google Scholar
  99. 99.
    Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354:1601–1613Google Scholar
  100. 100.
    Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, Rimm EB (2004) Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 79:606–612Google Scholar
  101. 101.
    Mensink RP, Zock PL, Kester AD, Katan MB (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77:1146–1155Google Scholar
  102. 102.
    Hu FB, Willett WC (2002) Optimal diets for prevention of cardiovascular disease. JAMA 288:2569–2578Google Scholar
  103. 103.
    Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willet WC (1997) Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337:1491–1499Google Scholar
  104. 104.
    Gannon MC, Nuttall FQ, Saeed A, Jordan K, Hoover H (2003) An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes. Am J Clin Nutr 78:734–741Google Scholar
  105. 105.
    Nuttall FQ, Gannon MC (2004) Metabolic response of people with type 2 diabetes to a high protein diet. Nutr Metab (Lond) 1:6Google Scholar
  106. 106.
    Gannon MC, Nuttall FQ (2004) Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 53:2375–2382Google Scholar
  107. 107.
    Papakonstantinou E, Panagiotakos DB, Zampelas A (2005) Mediterranean diet and the metabolic syndrome: the role of protein. Curr Nutr Food Sci 1:287–294Google Scholar
  108. 108.
    Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Padyab M, Hu FB, Willet WC (2007) Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 85:735–741Google Scholar
  109. 109.
    Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC (2000) Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr 72:912–921Google Scholar
  110. 110.
    Trichopoulou A, Lagiou P (1997) Healthy traditional Mediterranean diet — an expression of culture, history and lifestyle. Nutr Rev 55:383–389Google Scholar
  111. 111.
    Keys A, Grande F (1957) Dietary fat and serum cholesterol. Am J Public Health 47:1520–1530Google Scholar
  112. 112.
    Willet WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D (1995) Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 61[Suppl]:1402–1406Google Scholar
  113. 113.
    Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D (2000) Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev 9:869–873Google Scholar
  114. 114.
    Kris-Etherton P, Eckel RH, Howard BV, St Jeor S, Bazzarre TL; Nutrition Committee Population Science Committee and Clinical Science Committee of the American Heart Association (2001) AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation 103:1823–1825Google Scholar
  115. 115.
    Trichopoulou A, Costacou T, Bamia C, Trichopoulos D (2003) Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348:2599–2608Google Scholar
  116. 116.
    Martinez-Gonzalez MA, Fernandez-Jarne E, Serrano-Martinez M, Marti A, Martinez JA, Martin-Moreno JM (2002) Mediterranean diet and reduction in the risk of a first acute myocardial infarction: an operational healthy dietary score. Eur J Nutr 41:153–160Google Scholar
  117. 117.
    Oldways (2008) Preservation & Exchange Trust, Boston, MA. Accessed 27 Jan 2008
  118. 118.
    Bes-Restrollo M, Sanchez-Villegas A, de la Fuente C, de Irala J, Martinez JA, Martinez-Gonzalez MA (2006) Olive oil consumption and weight change: the SUN prospective cohort study. Lipids 41:249–256Google Scholar
  119. 119.
    Bes-Restrollo M, Sabate J, Gomez-Gracia E, Alonso A, Martinez JA, Martinez-Gonzalez MA (2007) Nut consumption and weight gain in a Mediterranean study: the SUN study. Obesity (Silver Spring) 115:107–116CrossRefGoogle Scholar
  120. 120.
    Alonso A, Beunza JJ, Delgado-Rodriguez M, Martinez JA, Martinez-Gonzalez MA (2005) Low fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr 82:972–979Google Scholar
  121. 121.
    Alonso A, de la Fuente C, Martin-Arrau AM, de Irala J, Martinez JA, Martinez-Gonzalez MA (2004) Fruit and vegetable consumption is inversely associated with blood pressure in a Mediterranean population with a high-vegetable-fat intake: the Seguimiento Universidad de Navarra (SUN) Study. Br J Nutr 92:311–319Google Scholar
  122. 122.
    Rosell M, De Faire U, Hellenius ML (2003) Low prevalence of the metabolic syndrome in wine drinkers — is it the alcohol beverage or the lifestyle? Eur J Clin Nutr 57:227–234Google Scholar
  123. 123.
    Kris-Etherton P, Harris W, Appel L (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747–2757Google Scholar
  124. 124.
    Parra B, Bandarra NM, Kiely M, Thorsdottir I, Martinez JA (2007) Impact of fish intake on oxidative stress when included into a moderate energy-restricted program to treat obesity. Eur J Nutr 46:460–467Google Scholar
  125. 125.
    Thorsdottir I, Tomasson H, Gunnarsdottir I, Gisladottir E, Kiely M, Parra MD, Bandana NM, Schaafsma G, Martinez JA (2007) Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes 10:1560–1566Google Scholar
  126. 126.
    Knapp HW (1997) Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 65:1687S–1698SGoogle Scholar
  127. 127.
    Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D’Armiento M, D’Andrea F, Giugliano D (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292:1440–1446Google Scholar
  128. 128.
    Ruiz-Gutierrez V, Muriana FJG, Guerrero A (1996) Plasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources. J Hypertens 14:1483–1490Google Scholar
  129. 129.
    Psaltopoulou T, Naska A, Orfanos P, Trichopoulos D, Mountokalakis T, Trichopoulou A (2004) Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 80:1012–1018Google Scholar
  130. 130.
    Assmann G, de Basker G, Bagnara S (1997) International Consensus statement on olive oil and the Mediterranean diet: implications for health in Europe. Eur J Cancer Prev 6:418–421CrossRefGoogle Scholar
  131. 131.
    Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C (2004) Adherence to the Mediterranean diet attenuates inflammation and coagulation process, in healthy adults: the ATTICA study. J Am Col Cardiol 44:152–158Google Scholar
  132. 132.
    Tortosa A, Bes-Rastrollo M, Sanchez-Villegas A, Basterra-Gortar FJ, Nuñez-Cordoba JM, Martinez-Gonzalez MA (2007) Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort. Diabetes Care 30:2957–2959Google Scholar
  133. 133.
    Williams DE, Prevost AT, Whichelow MJ, Cox BD, Day NE, Wareham NJ (2000) A cross-sectional study of dietary patterns with glucose intolerance and other features of the metabolic syndrome. Br J Nutr 83:257–266Google Scholar
  134. 134.
    de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N (1999) Mediterranean diet, traditional risk factors, and the risk of cardiovascular complications after myocardial infarction: final report of the Lyon Heart Study. Circulation 99:779–785Google Scholar
  135. 135.
    Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvadó J, Ruiz-Gutierrez V, Covas MI, Fiol M, Gomez-Gracia E, Lopez-Sabater MC, Vinyoles E, Arós F, Conde M, Lahoz C, Lapetra J, Saez G, Ros E; PREDIMED Study Investigators (2006) Effects of Mediiterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145:1–11Google Scholar
  136. 136.
    Pitsavos C, Panagiotakos DB, Chrysohoou C, Papaioannou I, Papadimitriou L, Tousoulis D, Stefanadis C, Toutouzas P (2003) The adoption of Mediterranean diet attenuates the development of acute coronary syndromes in people with the metabolic syndrome. Nutr J 2:1Google Scholar
  137. 137.
    Dandona P, Aljada A, Mohanty P (2002) The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45:924–930Google Scholar
  138. 138.
    Plotnick GD, Corretti MC, Vogel RA (1997) Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. JAMA 278:1682–1686Google Scholar
  139. 139.
    Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, Marfella R, Giugliano D (2002) Postprandial endothelial activation in healthy subjects and type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 39:1145–1150Google Scholar
  140. 140.
    Esposito K, Nappo F, Giugliano F, Giugliano G, Marfella R, Giugliano D (2003) Effect of dietary antioxidants on post-prandial endothelial dysfunction induced by a high-fat meal in healthy subjects. Am J Clin Nutr 77:139–143Google Scholar
  141. 141.
    Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Barbieri M, Paolisso G, Giugliano D (2003) Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 78:1135–1140Google Scholar
  142. 142.
    Serrano-Martinez M, Palacios M, Martinez-Losa E, Lezaun R, Maravi C, Prado M, Martinez JA, Martinez-Gonzalez MA (2005) A Mediterranean dietary style influences TNF-alpha and VCAM-1 coronary blood levels in unstable angina patients. Eur J Nutr 44:348–354Google Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • C. A. Vidurrizaga-De Amezaga
    • 1
  • M. A. Zulet
    • 1
  • A. Marti
    • 1
  • M. A. Martinez-Gonzalez
    • 2
  • J. A. Martinez
    • 1
  1. 1.Department of Nutrition and Food Sciences, Physiology and ToxicologyUniversity of NavarraPamplonaSpain
  2. 2.Department of Preventive Medicine, Epidemiology and Public HealthUniversity of NavarraPamplonaSpain

Personalised recommendations